17 records found.
Jan 22, 2020
Aruvant Receives Orphan Drug Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Nov 25, 2019
California to Expand Innovative Adult Sickle Cell Disease Clinics Statewide
Nov 18, 2019
New Sickle Cell Drug With Oklahoma Roots Receives FDA Approval
Nov 15, 2019
New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Nov 14, 2019
Sickle Cell Disease (SCD) Epidemiology Forecast to 2028: Focus on Turkey, Saudi Arabia, UAE, Mexico, Colombia, Brazil, and Argentina
Nov 04, 2019
Sickle Cell Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Sep 26, 2019
Emmaus Life Sciences Announces its Common Stock to Begin Trading on OTCQB September 26
Sep 19, 2019
Emmaus Life Sciences Announces Withdrawal of Marketing Authorization Application to European Medicines Agency
Aug 28, 2019
Emmaus Life Sciences Adds Oncology Supply as Distributor
Aug 14, 2019
Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida
Jul 24, 2019
Emmaus Life Sciences Brings "Sideline Sickle Cell" Campaign to Dallas for Participation in Annual Warriors Convention
Jul 11, 2019
Lovelace Biomedical & Exemplar Genetics Win New Contract to Develop New Model of Sickle Cell Disease
Jul 08, 2019
Emmaus Life Sciences Announces Initiation of its Diverticulosis Study
Jul 03, 2019
Emmaus Life Sciences Announces Hiring Of New Endari® Product Manager
Jun 18, 2019
Emmaus Life Sciences' 'Sideline Sickle Cell' Campaign Teams Up with SCTPN for World Sickle Cell Day Event on June 19
May 29, 2019
Emmaus Life Sciences Announces New CFO and EMA Opinion
May 13, 2019
California Leaders in Science and Policy Discuss Impacts of Sickle Cell Disease